首页> Clinics and research in hepatology and gastroenterology> Update on hepatocellular carcinoma breakthroughs: poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy.

Update on hepatocellular carcinoma breakthroughs: poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Clément,Guillot

第一单位： UMR INSERM U1052 CNRS5286, CRCL, 151, cours Albert-Thomas, 69008 Lyon, France; Université Lyon-1, 69622 Villeurbanne, France; International Agency for Research on Cancer, 150, cours Albert-Thomas, 69424 Lyon cedex 03, France.

作者： Clément,Guillot ^[1] ; Janet,Hall ^[2] ; Zdenko,Herceg ^[3] ; Philippe,Merle ^[4] ; Isabelle,Chemin ^[5]

作者单位： UMR INSERM U1052 CNRS5286, CRCL, 151, cours Albert-Thomas, 69008 Lyon, France; Université Lyon-1, 69622 Villeurbanne, France; International Agency for Research on Cancer, 150, cours Albert-Thomas, 69424 Lyon cedex 03, France. ^[1] Institut Curie, Centre de Recherche, Orsay, France; Inserm U612, Centre Universitaire, Orsay, France. ^[2] International Agency for Research on Cancer, 150, cours Albert-Thomas, 69424 Lyon cedex 03, France. ^[3] UMR INSERM U1052 CNRS5286, CRCL, 151, cours Albert-Thomas, 69008 Lyon, France; Université Lyon-1, 69622 Villeurbanne, France; Hospices Civils de Lyon, Service d'Hépatologie et de Gastroentérologie, Groupement Hospitalier Lyon Nord, Lyon, France. ^[4] UMR INSERM U1052 CNRS5286, CRCL, 151, cours Albert-Thomas, 69008 Lyon, France; Université Lyon-1, 69622 Villeurbanne, France. Electronic address: isabelle.chemin@inserm.fr. ^[5]